Home/Oncoteq/Mads Dalsgaard
MD

Mads Dalsgaard

Chief Executive Officer

Oncoteq

Therapeutic Areas

Oncoteq Pipeline

DrugIndicationPhase
TEQ102 (formerly TUB-010)Oncology (unspecified)Preclinical/Phase 1